1.Berger, M, Shiau, R, Weintraub, JW. Review of syndromic surveillance: implications for waterborne disease detection. Journal of Epidemiology & Community Health 2006; 60: 543–550.
2.Tuppin, P, et al. French national health insurance information system and the permanent beneficiaries sample. Revue d'Epidemiologie et de Sante Publique 2010; 58: 286–290.
4.Kesten, S, Rebuck, AS, Chapman, KR. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990. Journal of Allergy and Clinical Immunology 1993; 92: 499–506.
5.Fontbonne, A, Papoz, L, Eschwege, E. Drug sales data and prevalence of diabetes in France. Revue d'Epidémiologie et de Santé Publique 1986; 34: 100–105.
6.Papoz, L. Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. The EURODIAB Subarea C Study Group. Epidemiology 1993; 4: 421–427.
7.Vauzelle-Kervroedan, F, Forhan, A, Papoz, L. Regional prevalence of diabetes treated with oral hypoglycemic agents. Diabetes & Metabolism 1993; 19: 291–295.
8.Sartor, F, Walckiers, D. Estimate of disease prevalence using drug consumption data. American Journal of Epidemiology 1995; 141: 782–787.
9.Oreberg, M, et al. Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences. European Journal of Clinical Pharmacology 1992; 43: 449–454.
10.Beaudeau, P, et al. A time series study of anti-diarrheal drug sales and tap-water quality. International Journal of Environmental Health Research 1999; 9: 293–311.
11.Zeghnoun, A, et al. Air pollution and respiratory drug sales in the city of Le Havre, France, 1993–1996. Environmental Research 1999; 81: 224–230.
12.Pitard, A, et al. Short-term associations between air pollution and respiratory drug sales. Environmental Research 2004; 95: 43–52.
13.Harf, R, Dechamp, C. Pollinosis and use of anti-allergic drugs: ragweed in the Rhone-Alpine region. Revue des Maladies Respiratoires 2001; 18: 517–522.
14.Spitzer, WO, et al. The use of beta-agonists and the risk of death and near death from asthma. New England Journal of Medicine 1992; 326: 501–506.
15.Osborne, ML, et al. Use of an automated prescription database to identify individuals with asthma. Journal of Clinical Epidemiology 1995; 48: 1393–1397.
16.Payment, P. Epidemiology of endemic gastrointestinal and respiratory diseases: incidence, fraction attributable to tap water and costs to society. Water Science and Technology 1997; 35: 11–12.
17.Fourquet, F, et al. Acute gastroenteritis in children in France: estimates of disease burden through national hospital discharge data. Archives of Pediatrics 2003; 10: 861–868.
18.Warrell, DA, et al. The Oxford Textbook of Medicine, 4th edn. Oxford: Oxford University Press, 2003.
19.Desenclos, JC, Vaillant, V, Bonmarin, I. National surveillance of infectious diseases 1998–2000 [in French]. Saint Maurice, France: Institut de Veille Sanitaire, 2003, pp. 1–342.
20.Boussard, E, et al. Sentiweb: French communicable disease surveillance on the World Wide Web. British Medical Journal 1996; 313: 1381–1382.
21.Uhlen, S, Toursel, F, Gottrand, F. Treatment of acute diarrhea: management by private practice pediatricians. Archives of Pediatrics 2004; 11: 903–907.
22.Beaudeau, P, et al. Detection and investigation of outbreaks of infection related to tapwater. An integrated approach [in French]. Saint Maurice, France: Institut de Veille Sanitaire, 2007, pp. 1–108.